1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cabozantinib (C) exposure-response (ER) modeling of efficacy and safety endpoints as a function of clearance in patients (pts) with renal cell carcinoma (RCC)
    Meeting Abstract

    Jonasch, E.; Motzer, R. J.; Escudier, B.; Powles, T.; Markby, D. W.; Nielsen, J.; Lacy, S.; Choueiri, T. K.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Analysis of an online tool to explore evolving practice patterns in renal cell carcinoma (RCC)
    Meeting Abstract

    Kim, W.; Rosenthal, K.; Hutson, T. E.; Motzer, R. J.; Plimack, E. R.; Obholz, K.; Vinther, A.; Rini, B. I.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • S-TRAC trial: Sensitivity analyses of disease-free survival (DFS)
    Meeting Abstract

    George, D. J.; Pantuck, A. J.; Motzer, R. J.; Ravaud, A.; Escudier, B.; Staehler, M. D.; Serfass, L.; Krishnaswami, S.; Casey, M.; Lechuga, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Impact of new systemic therapies on overall survival (OS) of patients (pts) with metastatic castration resistant prostate cancer (mCRPC) in a hospital-based registry
    Meeting Abstract

    Francini, E.; Gray, K. P.; Shaw, G.; Evan, C.; Hamid, A.; Perry, C. E.; Kantoff, P. W.; Taplin, M. E.; Sweeney, C.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Everolimus (E) plus bevacizumab (B) is effective first-line treatment for patients (pts) with advanced renal cell carcinoma (RCC) with papillary features (PF): Results from a phase II trial
    Meeting Abstract

    Feldman, D. R.; Lee, C. H.; Molina, A. M.; Knezevic, A.; Chen, Y.; Chaim, J.; Coskey, D. T.; Ged, Y.; Tickoo, S.; Reuter, V. E.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Outcomes of metastatic chromophobe renal cell carcinoma (ChRCC) with sarcomatoid features (SF)
    Meeting Abstract

    Ged, Y.; Knezevic, A.; Chen, Y.; Redzematovic, A.; Carlo, M. I.; Lee, C. H.; Feldman, D. R.; Patil, S.; Motzer, R. J.; Voss, M. H.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Concurrent deletion of BRCA2 and RB1 and aggressive prostate cancer
    Meeting Abstract

    Chakraborty, G.; Armenia, J.; Mazzu, Y. Z.; Nanjangud, G.; Chadalavada, K.; Atiq, M. O.; Komura, K.; Yoshikawa, Y.; Khan, N.; Du, S. Y.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Evaluation of predictive biomarkers for nivolumab in metastatic clear cell renal cell carcinoma (mccRCC) using RECIST and immune-related (IR) RECIST
    Meeting Abstract

    Pignon, J. C.; Jegede, O.; Horak, C.; Wind-Rotolo, M.; Catalano, P. J.; Grosha, J.; Flaifel, A.; Novak, J.; Mahoney, K. M.; Freeman, G. J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Genomic alterations to refine prognostication of patients with metastatic renal cell carcinoma
    Meeting Abstract

    Bosse, D.; Xie, W.; Lalani, A. K. A.; de Velasco, G.; Voss, M. H.; Tannir, N. M.; Tamboli, P.; Appleman, L. J.; Rathmell, K.; Heng, D. Y. C.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Safety and efficacy of the selective FGFR inhibitor debio 1347 in phase I study patients with FGFR genomically activated advanced biliary tract cancer (BTC)
    Meeting Abstract

    Cleary, J. M.; Voss, M. H.; Meric-Bernstam, F.; Hierro, C.; Heist, R. S.; Ishii, N.; Kirpicheva, Y.; Nicolas-Metral, V.; Pokorska-Bocci, A.; Vaslin, A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save